Safety of Biologics Therapy - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Safety of Biologics Therapy write by Brian A. Baldo. This book was released on 2016-08-12. Safety of Biologics Therapy available in PDF, EPUB and Kindle. This long overdue title provides a comprehensive, up-to-date, state-of-the art review of approved biologic therapies, with coverage of mechanisms of action, Indications for therapy, immunogenicity and a detailed examination of adverse effects and safety of the many and diverse therapeutic agents presented in a total of 13 chapters. It is predicted that by 2016, biologics will make up half of the world's 20 top-selling drugs and by 2018, biologic medicine sales will account for almost half of the world's 100 biggest selling drugs. Recombinant proteins dominate the growing list of the more than 200 approved biotherapeutic agents with targeted antibodies, fusion proteins and receptors; cytokines; hormones; enzymes; proteins involved in blood-clotting, homeostasis and thrombosis; vaccines; botulinum neurotoxins; and, more recently, biosimilar preparations, comprising the majority of approved biologics. Written with clinicians, other health care professionals, and researchers in mind, Safety of Biologics Therapy examines, in a single volume, the full range of issues surrounding the safety of approved biologic therapies. A good understanding of the risks and safety issues of modern biologics therapy is increasingly being demanded of all those connected with their development, handling, prescribing, administration and subsequent patient management. In addition to being of great value to clinicians in all branches of medicine, and to nurses, pharmacists and researchers, this book will prove invaluable for students taking undergraduate and graduate courses in the above disciplines and in the biomedical sciences.
Safe and Effective Medicines for Children
Safe and Effective Medicines for Children - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Safe and Effective Medicines for Children write by Institute of Medicine. This book was released on 2012-10-13. Safe and Effective Medicines for Children available in PDF, EPUB and Kindle. The Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equity Act (PREA) were designed to encourage more pediatric studies of drugs used for children. The FDA asked the IOM to review aspects of pediatric studies and changes in product labeling that resulted from BPCA and PREA and their predecessor policies, as well as assess the incentives for pediatric studies of biologics and the extent to which biologics have been studied in children. The IOM committee concludes that these policies have helped provide clinicians who care for children with better information about the efficacy, safety, and appropriate prescribing of drugs. The IOM suggests that more can be done to increase knowledge about drugs used by children and thereby improve the clinical care, health, and well-being of the nation's children.
Adverse Reactions to Biologics
Adverse Reactions to Biologics - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Adverse Reactions to Biologics write by L. Puig. This book was released on 2017-11-07. Adverse Reactions to Biologics available in PDF, EPUB and Kindle. In many areas of medicine physicians still face the great challenge of finding therapies that will meet the patients’ needs. In dermatology the challenge has arisen on multiple fronts through advances in the understanding of the immunopathogenesis of many inflammatory and malignant cutaneous disorders. Breakthroughs, combined with significant developments in targeted immunotherapy, have resulted in improved outcomes as these newer therapies are being used for both approved indications and as off-label therapies for various chronic inflammatory skin disorders and many forms of skin cancer. In the expectation that by truly understanding the safety profile of these targeted therapies patients’ outcomes will be significantly improved, this book offers insights into topics such as adverse reactions, infectious complications and the perioperative use of biologics in psoriasis, immunogenicity of biologic therapies, paradoxical reactions, safety of biologics used to treat autoimmune bullous diseases and primary cutaneous lymphomas, adverse reactions and skin manifestations of therapies targeting melanoma and non-melanoma skin cancer and other neoplastic diseases. Eminent researchers with extensive clinical experience have contributed to this publication, providing an in-depth overview of the latest knowledge in this field.
Rare Diseases and Orphan Products
Rare Diseases and Orphan Products - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Rare Diseases and Orphan Products write by Institute of Medicine. This book was released on 2011-04-03. Rare Diseases and Orphan Products available in PDF, EPUB and Kindle. Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.
Biologics, Biosimilars, and Biobetters
Biologics, Biosimilars, and Biobetters - read free eBook in online reader or directly download on the web page. Select files or add your book in reader. Download and read online ebook Biologics, Biosimilars, and Biobetters write by Iqbal Ramzan. This book was released on 2021-02-03. Biologics, Biosimilars, and Biobetters available in PDF, EPUB and Kindle. A comprehensive primer and reference, this book provides pharmacists and health practitioners the relevant science and policy concepts behind biologics, biosimilars, and biobetters from a practical and clinical perspective. Explains what pharmacists need to discuss the equivalence, efficacy, safety, and risks of biosimilars with physicians, health practitioners, and patients about Guides regulators on pragmatic approaches to dealing with these drugs in the context of rapidly evolving scientific and clinical evidence Balances scientific information on complex drugs with practical information, such as a checklist for pharmacists
